| Role of crystal disorder and mechanoactivation in solid-state stability of pharmaceuticals J Iyer, M Brunsteiner, D Modhave, A Paudel Journal of Pharmaceutical Sciences 112 (6), 1539-1565, 2023 | 10 | 2023 |
| Assessment of diverse solid− state accelerated autoxidation methods for droperidol J Iyer, I Saraf, A Ray, M Brunsteiner, A Paudel Pharmaceutics 14 (6), 1114, 2022 | 7 | 2022 |
| Theoretical and experimental investigation of autoxidation propensity of selected drugs in solution state J Iyer, M Brunsteiner, A Ray, A Davis, I Saraf, A Paudel Molecular Pharmaceutics 20 (3), 1768-1778, 2023 | 5 | 2023 |
| Mechanoactivation as a tool to assess the autoxidation propensity of amorphous drugs J Iyer, M Barbosa, I Saraf, JF Pinto, A Paudel Molecular Pharmaceutics 20 (2), 1112-1128, 2023 | 4 | 2023 |
| Applying material science principles to chemical stability: modelling solid state autoxidation in mifepristone containing different degrees of crystal disorder J Iyer, LM Morgan, P Harrison, A Davis, A Ray, S Mitsche, F Hofer, I Saraf, ... Journal of Pharmaceutical Sciences 112 (9), 2463-2482, 2023 | 2 | 2023 |
| Screening autoxidation propensities of drugs in the solid-state using PVP and in the solution state using N-Methyl pyrrolidone J Iyer, A Karn, M Brunsteiner, A Ray, A Davis, I Saraf, A Paudel Pharmaceutics 15 (3), 848, 2023 | 2 | 2023 |
| Influence of Crystal Disorder on the Forced Oxidative Degradation of Vortioxetine HBr D Modhave, B Barrios, J Iyer, A Paudel AAPS PharmSciTech 25 (1), 10, 2023 | | 2023 |
| Milling-induced amorphisation in Mifepristone and the implications on oxidative stability J Iyer, M Brunsteiner, I Saraf, A Paudel Session A: Analytics I, 0 | | |
amrit paudelRCPE - Research Center Pharmaceutical Engineering在 rcpe.at 的电子邮件经过验证
